Home page > Europe and Health > EU Funding and programmes

27/01/2016

[Joint NGO Statement] European civil society organisations call for the rejection of the EU Trade Secrets Directive

Brussels, 27 January 2016 - With regard to the upcoming vote on the proposed ’Trade Secrets Directive’ in the Legal Affairs Committee of the European Parliament (JURI) scheduled for 28 January 2016, a coalition of NGOs issued a joint statement colling for the rejection of the directive as legal uncertainty endangers access to information. EPHA joined the call as the concept of ’trade secrets’ could harm public health and can undermine public access to data on the (...)
29/09/2015

General Data Protection Regulation - EPHA progress report calls for health research exemption in trilogue negotiations

The General Data Protection Reform (GDPR) entered into the trilogue phase in June with the aim of concluding discussions at the end of 2015 or soon thereafter. A new EPHA progress report describes the challenges of the GDPR experienced so far and confirms the crucial role of data for health research and science purposes. In 2012, following the release of the European Commission’s proposal for a draft regulation (setting out a general EU framework for data protection) and a draft (...)
27/05/2015

[Event announcement] Launch of the MEP Friends of the Liver Interest Group - 27 May

MEP Cristian-Silviu Buşoi (EPP, RO) will launch the ’MEP Friends of the Liver Group’. The event is organised in collaboration with the European Association for the Study of the Liver (EASL). 27 May 2015, 13.00 – 15.00 | Venue: The European Parliament (Brussels) | JÓZSEF ANTALL (JAN), Room 6Q1. REGISTER HERE (Deadline: Wednesday, 20 May 2015) AGENDA CONCEPT NOTE MEP Friends of the Liver Interest Group: Dr Cristian-Silviu Buşoi, the European Association (...)
5/02/2015

[Event report] HEPAMAP: A Roadmap for EU Liver Research

On 10 December 2014, in an event hosted by MEP Cristian Buşoi (EPP, RO) in the European Parliament, the European Association for the Study of the Liver (EASL) launched the ‘Research Roadmap for Liver Disease (HEPAMAP) - Case study for chronic diseases & research’. The HEPAMAP stresses the need for further research on liver disease and calls on policy makers to step up their efforts to tackle the disease and its links with lifestyle and other diseases, such as (...)
2/02/2015

[EPHA consultation response] Science 2.0: Science in Transition

EPHA responded to the European Commission consultation on science in transition, emphasizing that epidemiological research should be an important component of the EU’s Horizon 2020 research programme. The primary focus of health research should be to improve public health and to reduce health inequalities. This includes research on population level interventions: improving the social and environmental determinants of health, understanding health behaviours, promoting continuity of (...)
11/12/2014

[EASL Press Release] Liver disease in Europe: new study reveals pressing need to focus on research and policy action

Brussels, 10 December 2014 – Today, in an event hosted by MEP Cristian Buşoi (EPP, RO) in the European Parliament, the European Association for the Study of the Liver (EASL) (1) launched the ‘Research Roadmap for Liver Disease (HEPAMAP) - Case study for chronic diseases & research’ (2). The HEPAMAP stresses the need for further research on liver disease and calls on policy makers to step up their efforts to tackle the disease and its links with lifestyle and other (...)
18/12/2014

Support the European Data in Health Research Alliance!

A new European Data in Health Research Alliance was launched in early December. This campaign, supported by a number of health organisations active across Europe and representing research, patient and public health concerns, was set up to demonstrate in the most tangible way that personal data in research is vital because it saves lives. The Alliance was established by Cancer Research UK, the Medical Sciences Committee of Science Europe, European Patients’ Forum, the Federation of (...)
5/11/2014

Carlos Moedas » European Commissioner for Research, Science and Innovation

Carlos Moedas (age 44) studied engineering at Lisbon University, Portugal and an MBA at Harvard University, USA. He worked for Goldman Sachs and EuroHypo investment bank before returning to Portugal in 2004 to join a property consulting company, and established his own property investment company in 2008. He led negotiations for the Social Democratic Party (PSD) for Portugal’s 2011 State Budget. He was elected as an MP in the same year, and leading implementation of the (...)
26/09/2014

5th ESWI Influenza Conference highlights benefits of vaccination

The fifth international influenza conference organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place in Riga on 14-17 September. A number of plenary and ’science/policy interface’ sessions examined the issue of low vaccination uptake in many Member States, as well as other issues related to pandemic preparedness and communication aspects of influenza-related health threats. In the opening plenary, ’Why should influenza be a public (...)
5/06/2014

[EPHA statement] On-going review of European Food Safety Authority 2012 implementing rules of the Declaration of Interests Policy

On 15 December 2011, the European Food Safety Authority (EFSA) Management Board adopted its Authority’s Policy on independence and scientific decision-making processes. A few months later EFSA’s Executive Director signed off a set of implementing rules on Declarations of Interests (DoIs). These rules regulate the way EFSA should process DoIs and prevent the occurrence of conflicts of interests. Background The current system of declarations of interests and their subsequent (...)

0 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | ...